£49.07

This is the most expensive it has ever been. Walk away.

£49 today · previous high £49 · all-time low £44

Chapman and Hall/CRC Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£49.07 £43.48 £44.70 £45.92 £47.14 £48.36 £49.58 25 July 2026 07 August 2026 21 August 2026 04 September 2026 18 September 2026
View at Amazon ↗

Price data last checked 35 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 56 days • 3 price levels

Days at Price
Current Price
13 days 39 days 4 days · current 0 10 20 29 39 £44 £46 £49 Days at Price

Price Analysis

Most common price: £46 (39 days, 69.6%)

Price range: £44 - £49

Price levels: 3 different prices over 56 days

Description
Real-world evidence is defined as evidence generated from real-world data outside randomized controlled trials. As scientific discoveries and methodologies continue to advance, real-world data and their companion technologies offer powerful new tools for evidence generation. Real-World Evidence in a Patient-Centric Digital Era provides perspectives, examples, and insights on the innovative application of real-world evidence to meet patient needs and improve healthcare, with a focus on the pharmaceutical industry. This book presents an overview of key analytical issues and best practices. Special attention is paid to the development, methodologies, and other salient features of the statistical and data science techniques that are customarily used to generate real-world evidence. It provides a review of key topics and emerging trends in cutting-edge data science and health innovation. Features: Provides an overview of statistical and analytic methodologies in real-world evidence to generate insights on healthcare, with a special focus on the pharmaceutical industry Examines timely topics of high relevance to industry such as bioethical considerations, regulatory standards, and compliance requirements Highlights emerging and current trends, and provides guidelines for best practices Illustrates methods through examples and use-case studies to demonstrate impact Provides guidance on software choices and digital applications for successful analytics Real-World Evidence in a Patient-Centric Digital Era will be a vital reference for medical researchers, health technology innovators, data scientists, epidemiologists, population health analysts, health economists, outcomes researchers, policymakers, and analysts in the healthcare industry.

Key Features

New Store Stock

Product Specifications
Brand
Chapman and Hall/CRC
Format
paperback
ASIN
103230362X
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain
Amazon UK
Release Date
26 August 2024
Listed Since
22 June 2024

Barcode

No barcode data available

Similar Products You Might Like

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
99% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.36 24 Sep 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
97% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.44 23 Sep 2026
Design and Analysis of Clinical Trials: Concept and Methodologies (Wiley Series in Probability and Statistics)
97% match

Design and Analysis of Clinical Trials: Concept and Methodologies (Wiley Series in Probability and Statistics)

Wiley

£87.02 11 Sep 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
97% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£120.00 17 Sep 2026
Statistical Methods in Biomarker and Early Clinical Development
97% match

Statistical Methods in Biomarker and Early Clinical Development

Springer

£100.08 24 Sep 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
97% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£77.05 01 Oct 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£138.45 11 Sep 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
97% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£64.03 22 Sep 2026
Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
97% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£50.99 11 Sep 2026
Clinical Trial Biostatistics and Biopharmaceutical Applications
97% match

Clinical Trial Biostatistics and Biopharmaceutical Applications

CRC Press

£100.00 12 Sep 2026
Success Probability Estimation with Applications to Clinical Trials
97% match

Success Probability Estimation with Applications to Clinical Trials

Wiley

£84.95 12 Sep 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
97% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 17 Sep 2026
Jones & Bartlett Evidence-Based Practice for Health Professionals
97% match

Jones & Bartlett Evidence-Based Practice for Health Professionals

Jones & Bartlett Learning

£28.53 19 Sep 2026
Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
97% match

Innovative Strategies, Statistical Solutions and Simulations for Modern Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£120.00 24 Sep 2026
Wiley Individual Participant Data Meta-Analysis Handbook
97% match

Wiley Individual Participant Data Meta-Analysis Handbook

Wiley

£60.88 13 Sep 2026
Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)
96% match

Pharmaceutical Statistics Using SAS: A Practical Guide (SAS Press)

SAS Institute

£70.10 02 Oct 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
96% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 23 Sep 2026
Statistical Methods for Dose-Finding Experiments: 24 (Statistics in Practice)
96% match

Statistical Methods for Dose-Finding Experiments: 24 (Statistics in Practice)

Wiley

£86.96 17 Sep 2026
Clinical Research Law and Ethics: Human Research and a Complete Practical Guide to Regulatory Compliance
96% match

Clinical Research Law and Ethics: Human Research and a Complete Practical Guide to Regulatory Compliance

£80.77 11 Sep 2026
A Concise Guide to Clinical Trials
96% match

A Concise Guide to Clinical Trials

Wiley

£46.64 26 Sep 2026
Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
96% match

Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£48.99 11 Sep 2026